Skip to content

Prophylactic Effect of StrataXRT Gel on Radiation Therapy Induced Dermatitis

The Investigation of Prophylactic Effect of StrataXRT Gel on Radiation Therapy Induced Dermatitis in Breast Cancer Patients.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181030041507N1
Enrollment
100
Registered
2018-12-31
Start date
2018-12-22
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation Induced Dermatitis in Breast Cancer.

Interventions

Intervention 1: Intervention group: One group of patients from the first day will use the StrataXRT gel twice daily and 5 consecutive days per week for 5-5.5 weeks on radiotherapy area, which has alre

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: All patients with newly diagnosed breast cancer undergoing radical mastectomy and candidate for radiation therapy. Signing the informed consent form. No contraindication for radiotherapy. Three weeks after chemotherapy. Not receiving simultaneously chemotherapy and Herceptin.

Exclusion criteria

Exclusion criteria: All patients with history of radiation therapy of breast. A history of systemic or cutaneous diseases such as diabetes mellitus or collagen vascular disease, and concomitant use of wound healing drugs such as systemic steroids.

Design outcomes

Primary

MeasureTime frame
Low Grade Skin Inflammatory Changes. Timepoint: Weekly. Method of measurement: Direct Observation and Transparent Sheet.

Secondary

MeasureTime frame
Efficacy of StrataXRT gel. Timepoint: Weekly. Method of measurement: Examining the patient's medical records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Eskandari

Shiraz University of Medical Sciences

Z.e01365@gmail.com+98 71 4352 3347

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026